Why Is Apellis Pharmaceuticals Stock Trading Lower Today?
Shares of Apellis Pharmaceuticals Inc APLS declined following a report by Citron Research casting doubts on the company's prospects and the safety of its recently approved treatment for Geographic Atrophy, Syfovre. The report anticipates an FDA warning letter and criticizes the lack of…
#citronresearch #geographicatrophy #fda #cedricfrancois #citron #favusresearch #syfovre #asrs #apellis #empaveli